chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial case was received on 28 October 2010 from a healthcare professional. A 59 year old female patient received on 15 September 2010 a left deltoid intramuscular injection of ADACEL (lot number C3491AA) and right deltoid intramuscular injection of FLUZONE (lot number U3619EA). In the PM of the day of the vaccines, the patient experienced a red, sore arm. She was seen in the doctor's office on 21 October 2010 and the dimensions were 11 and a half centimeters (cm) by 20 cm of erythema with "central induration". The patient was treated with BACTRIM which was ineffective. She was then treated with KEFLEX which "helped somewhat." She also used topical creams (not specified) on the area. The patient had no illness at the time of the vaccines. She had no known allergies. Pre-existing medical conditions included asthma and her concomitant medication was Albuterol. At the time of this report, the patient had not recovered. Documents held by sender: None.
pt recv vax 8SEP97 &  45min laster pt exp vertigo, dizziness, flushing of the face & burning of both cheeks;felt like face was on fire;
extreme arm pain; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of unknown age started to receive first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration as a single dose on 08Apr2021 for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received Pfizer COVID vaccine first dose on 08Apr2021 and had experienced "extreme arm pain every day since. Patient did not remember if it was that evening or in the morning, some days are worse than others, it was sad what had been going through had been affecting my activities. Patient was supposed to get second dose on Thursday. Patient wanted to know the efficacy percentage from Pfizer after a single dose of this vaccine, stated she has "heard all over, everywhere that some people took 1 dose and may be fine with it being 50% or something and second 95%. Response received as alternative dosing regimens of Pfizer-BioNTech COVID-19 Vaccine have not been evaluated. The decision to implement alternative dosing regimens resides with health authorities; however, we at Pfizer believe that it was critical for health authorities to conduct surveillance on implemented alternative dosing schedules to ensure that vaccines provide the maximum possible protection. The outcome of the event was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
On 03/03/05 mother brought pt in for immunizations on 3/1/05. Mom returned to clinic with pt c/o swelling, redness, warmth on left arm which she noticed on 3/2/05 AM.
Patient stated feeling dizzy, denied history of HTN and her BP was 172,96. observed for an hour left with BP of 164/93 with education of when to seek medical attention bc her CAB was here and she claimed she was anxious but the dizziness subsided
PATIENT WAS ADMINISTERED THEIR SECOND DOSE OF MODERNA COVID-19 VACCINE 22 DAYS AFTER RECEIVING THEIR FIRST DOSE INSTEAD OF THE MINIMUM 24 DAYS REQUIRED. THE DOSE WAS FLAGGED AS INVALID IN THE PATIENT'S  IMMUNIZATION RECORD. THERE ARE NO KNOWN ADVERSE EVENTS ASSOCIATED WITH THIS PATIENT AT THIS TIME.  THE PATIENT INDICATED ON AGENCY FORM PREVACCINATION CHECKLIST FOR COVID-19 VACCINES QUESTION 2 THAT SHE HAD NOT PREVIOUSLY RECEIVED ANY DOSE OF COVID-19 VACCINE.  If a dose is inadvertently administered before the 4-day grace period, it does not need to be repeated. This means that when reviewing records, a second dose of Moderna COVID-19 Vaccine administered 23 or less days after the first dose does not need to be repeated. This is considered a vaccine administration error. Determine how the error occurred and implement strategies to prevent it from happening again. Additionally, you are required to report COVID-19 vaccine administration errors to the Vaccine Adverse Event Reporting System
Presented with SOB; + covid:  instituted on oxygen supplementation, nebulizer treatment and respiratory protocol.Tx: Maxipime, Rocephin, eliquis, doxycycline, zinc:  His routine medications for underlying chronic medical conditions were continued.  Patient did not meet criteria for remdesivir and steroid therapy.  He had a follow-up chest x-ray on 02/05/2022 that showed no acute chest disease.  Chest CT obtained on 02/05/2022 showed consolidation in the left lung base likely represents atelectasis. O2 @ room air at d/c.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unspecified demographics. Approximately on an unknown date in 2013 (reported as between 18-FEB-2013 and 11-JUN-2013), an unknown number of patients might have received dose of PEDVAXHIB (dose, lot number and expiry date was unspecified) that had been improperly stored. Concomitant therapy was unspecified. No adverse effects reported. No product quality complaint was involved. The outcome of patients might have received improperly stored PEDVAXHIB was unknown. No further information was provided. This is one of the several reports from the same source. Additional information has been requested.
Had swollen lymph node under left armpiot (1st dose) for 3-4 weeks. Had a small swollen lymph node on right armpit after second dose.  About 10 days after second vaccine, I had an ear ache. The next day the left side of my neck was swollen and the left side of my forehead and eye tingled and hurt. I took ibuprofen for 2 days and the lymph nodes started swelling. The 3rd day I woke up with rashes. I went to the doctor and I had shingles in eye. I had blurry vision by the time I got the doctor.
Severe difficulty breathing; Blood pressure shot up to 200; Troponin level jumped up; A spontaneous report was received from a non-health professional concerning a 77-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe difficulty breathing and that his troponin level and blood pressure (BP) had shot up.  The patient's medical history included chronic obstructive pulmonary disease (COPD). Concomitant product use was not provided by the reporter.  On 09 Jan 2021, at approximately 14:42, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 09 Jan 2021 at 20:30, the patient experienced severe difficulty breathing and his BP shot up to 200. The patient went to the hospital and they found his troponin levels had jumped up. The patient reported no known heart issues. On 12 Jan 2021, he went to see his primary care physician (PCP).  No treatment information for the event was provided.   Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome for the events, severe difficulty breathing and  troponin level and blood pressure (BP) had shot up, were unknown.; Reporter's Comments: This case concerns a 77-year-old, male patient, with medical history of chronic obstructive pulmonary disease (COPD), who experienced a serious, unexpected event of dyspnoea, hypertension and raised troponin level. The event occurred 5 hours 48 min after the first dose of mRNA-1273 (Lot number: 039K20A).  Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded.
Patient told pharmacist that she has fainted from vaccines before, so pharmacist had her sit in the room after the vaccine was administered. About 5 minutes after administration, patient said she was starting to get sweaty and opted to lie down on the floor. We gave her a bottle of water. She then stated she was experiencing nausea and grabbed trash can and vomited. Pharmacist had patient remain in room for an additional 30 minutes with pharmacist, in which she said she was feeling more normal as the time passed. She said she had never actually vomited after a vaccine before, but has felt nauseas after before fainting. No additional treatment was administered.
Hospitalized 11/25/2021; COVID-19 positive 11/25/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider: FNP Admission Date: 11/25/2021 Discharge Date: Nov 29, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01]  HOSPITAL COURSE: Very pleasant 20 y/o WM single community dwelling patient was admitted on 11/25 for acute respiratory failure with hypoxia secondary to bilateral COVID 19 pneumonia.  He had the J&J vaccine in April 2021.   He received supplemental oxygen and was compliant with prone positioning when instructed.  When supine he had signfiicant apnea and needed CPAP for adequate oxygenation.  His BMI is 63.   He received Remdesivir and Decadron, as well as MDI's and supportive medications.  He was monitored in CCU until 11/28 due to his large size and potential for decompensation.  Fortunately, he continued to improve daily.   On 11/29, he required RA oxygen.  A home oxygen evaluation confirmed the same.  He was deemed medically stable for discharge.   He needs a sleep study for his OSA.   He needs a follow up CMP to re-evaluate the AST, ALT s/p Remdesivir.   He should follow up with his PCP in a week after admission.  He may return to work in 1 week as well.
Patient received vaccines on 01/08/2018, then on 01/09/2018 mother of patient reports that the patient woke up with a temperature of 103.3 and was unusually fussy. Upon arriving to our pediatrics office we took the patient's temperature auxiliary and it was 102.3, so we gave 1.6 ml of Ibuprofen. No other symptoms were reported by the mother, and no other symptoms were noted/reported by the doctor.
SORE ARM AT INJECTION SITE; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821288, and expiry: 15-SEP-2021) dose was not reported, administered on 02-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm at injection site was not reported. This report was non-serious.
Extreme soreness in right arm, chills, soreness, aches, sensitive skin to touch
chills; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 24-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 24-Feb-2021, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Child is 12 but received the 5-11 y.o. Pfizer.
Swelling and confusion advised to the ed call 911  Sister calls for 91 year old sister that caretaker called and stated patient more confused today and is swollen face arms legs abdomen.    advised to call 911.  sister had little info ,  list given of information needed to complete adverse event chart  Taken to Hospital, diagnosed with a UTI, on antibiotics. Feeling much better an symptoms resolving per sister. Taken to Hospital, diagnosed with a UTI, on antibiotics. Feeling much better an symptoms resolving per sister.
Developed generalized hives/rash 13 days post covid booster vaccine. I?m on day 6 and still dealing with generalized hives that pop up in random locations on my body that are very itchy and also red rashes. These will appear for about 30 minutes or so and then disappear, only to reappear in a different location on my body 60 minutes later. Went to my Dr office and was prescribed the 4 mg medrol dose pack for 6 days as well as OTC Benadryl and or Zyrtec. Still with little to no relief of the hives or rashes. Delayed hypersensitivity reaction to the booster vaccine??
Patient arm at the site of injection looks dark red, surrounded by a wide area of pale red. Patient stated that the area feels warm and itchy and raised as well. Patient stated that the adverse reaction started Friday night (About one day after the vaccine was given).
Approximately 24 hours after receipt of Td in left deltoid and Hep B number 1 in R deltoid. Noted swelling superior to right clavicle and sternomastoid muscle. Positive lymphadenopathy. Without localized reaction at site. Exam findings otherwise negative. Symptoms resolved within 72 hours.
pt recv vax;exp Bell's palsy&was hosp;reporter felt that Bell's palsy not related to vax;
Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Document received on 16-Jun-2021 and it contains Patient denies having access to Fax/email. States that diarrhea was due to the flu and not from the vaccine.Requested to be removed from call list.
Sore Arm, Vomiting, Vaccine was administered with out diluent.
Pt received 4th Anthrax vaccine shot left triceps on 18 Dec 03.  Within 24 hours developed redness, swelling itching, and pain, radiating down arm.  Redness progressed, measured at 17cm on Saturday eve 20 Dec 03.  Pt had no difficulty breathing.  He did have some elbow and wrist joint pain, with some pins and needles sensation in left hand.
DTaP-IPV component of PENTACEL administered IM R. thigh then PENTACEL (Diphtheria, Tetanus Toxoids + Acellular Pertussis Adsorbed Inactivated Polio virus + hemophilus B conjugate) administered R thigh due to DTaP-IPV component only being invalid at time of visit. After immunizing patient with PENTACEL we realized that dose of DTaP-IPV component is a valid dose for DTaP-IPV. Patient should of received HIB dose to complete series but instead received a dose of PENTACEL at same visit.
First shot: right arm pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number: EW0173), via an unspecified route of administration, administered in arm right on 30Apr2021 (at the age of 37-years-old), at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were reported as none. After first shot, the patient developed right arm pain on an unspecified date in 2021. Outcome of the event was resolved on an unspecified date in 2021.  Information on the lot/batch number has been requested. Follow up needed, further information has been requested.
Pain all over the body as if was in a car accident.  Every muscle and joint was hurting.  Extreme back pains, chills, loss of appetite, fever and headache.  Upper chest area sore from shoulder, right leg and but cheek is sore.
muscle stiffness and soreness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (muscle stiffness and soreness) and ARTHRALGIA (joint pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (muscle stiffness and soreness) and ARTHRALGIA (joint pain). At the time of the report, MUSCULOSKELETAL STIFFNESS (muscle stiffness and soreness) and ARTHRALGIA (joint pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment details were provided.
Approximately 24 hours after the administration of the vaccine the patient experienced a fever of 110.6, and left work and remained out for 24 hours. The patient proceeded to experience GI symptoms which presented as diarrhea for 10 days post vaccination. The fever resolved after 24 hours. The patient experienced pain in joints, this has continue and not yet resolved, the patient has made an appoint with their primary physician to address the matter. The patient is currently taking ibuprofen to treat the pain.
Pulmonary embolism DVT in right leg  Treatment: 8 days in hospital, after hospital Eliquis, 5 mg twice per day from June 2021 - January 2022. Scans of legs and lungs every three months, visits with pulmonologist, consultation with vascular surgeon, and currently undergoing examinations with hematologist. At present, no underlying blood condition observed that could have caused clots.
Itchiness at the injections site; sore muscles; headache; diarrhea; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 42-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 42-year) in Left Arm on 10Feb2021 at 10:30 AM as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications. Historical vaccine includes first dose of BNT162B2 administered in left arm on 22Jan2021 at 11:00 AM for COVID-19 immunization. As reported Facility type vaccine was Hospital. No known allergies were reported. No COVID prior vaccination was reported. The patient was not tested COVID post vaccination. The patient received no other vaccine in four weeks; and no other medications in two weeks. On 10Feb2021 at 07:00 PM the patient experienced itchiness at the injections site, sore muscles, headache, diarrhea. No treatment was received by the patient for the adverse events. The clinical outcome of the events was recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Over the past several years, a lot of aches in joints, taking cortisone shots in feet, Celebrex, lots of Advil. Still seeing doctors. Sleep a lot cannot work all day I ache so much. 1st dose 4/19/99, 2nd on 5/18/99, 3rd on 5/9/2000.
High cholesterol, alopecia (hair loss), mood anxiety, cold and flu symptoms, concentration difficulty, depression, delirium episodes, fatigue and pain hemorrhoids, memory loss, trouble finding words, weight loss, speech disorder.
skin rash all over body, muscle aches, fever comes and goes, headache sinus headache, extreme fatigue, brain fog, lasted two weeks started to abate, another week before strength came back to normal, another week after that before brain fog went away, night sweats,
About 14 hours after getting the shot, I was awoken to slight pain in my chest at what seemed to be rib #3.  This would be the end of the rib at the center of my chest. I didn?t think much of it at that time. When I woke up around 0600, the pain was throughout the center of my chest. The more I exerted myself, the greater the pain. I also had a headache and neck pain. After 36 hours, I was fine. I didn?t go to the ER as I felt that the problem was muscular. My heart felt fine.
6 hours post vax, the pt developed a rash that started on her abdomen spreading to become generalized erythematous maculopapular with positive itching. Also, fever of 100.4.
Lower than authorized dose volume (0.25 ml) administered, once identified patient notified and returned for additional 0.25 ml to equate to 0.5 ml (recommended third dose of Moderna COVID-19 vaccine for immunocompromised patients), per  recommendation via CDC COVID-19 Vaccine Administration Errors and Deviations.
Injection site pain, bodyaches, joint pain, muscle tightness, headache, racing heart, fever (100.5), loss of appetite, nausea, vomiting.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 17-DEC-2016, the patient was vaccinated with an expired dose of ZOSTAVAX with lot number L035505 and expiration date of 16-DEC-2016 (strength, dose, route of administration and anatomical location were unknown) for prophylaxis. There were no concomitant therapies nor adverse symptoms reported. The reporter also stated that ZOSTAVAX did not have any previous temperature excursions. No product quality complaint was involved.       Additional information has been requested.
The patient presented to a vaccination clinic at the local Human services building hosted by local Pharmacy. The aid that was responsible for the patient indicated that the patient was to get a SHINGRIX vaccine. Upon billing to the patient's insurance, the claim rejected saying that 2 doses were already received previously. Upon follow-up with the Nurse Manager, she confirmed that the patient did already receive 2 doses of SHINGRIX and the aid was incorrect to request the 3rd dose. There was no history of SHINGRIX vaccines found in the local data tracking system.
Patient initially had small lump at injection site, later developed a small rash less than 1/4 inch red raised area about 1 inch from injection site. Area in tender to touch and complains of an aching in that area of his arm.
Patient received a Moderna BvlntBstr dose on 06/21/2023 (Lot AS7185B) for their first dose in the COVID-19 vaccine series. They were supposed to receive a second dose of Moderna BvlntBstr for the second dose of COVID-19 vaccine but they received a dose of Pfizer BvlntBstr 6M-4Y instead. Patient has no adverse symptoms from this vaccine administration to our knowledge. It was just an error in vaccine type administered.
Patient reported to me 6 hours after vaccine feeling flushed, generalized skin redness (not just at site of inj.). Felt throat closing up/cough-sxs resolved quickly. Then persistent red rash at injection site no vesicles with surrounding swelling, erythema arm.
She took flu vaccine last year OK, prior not a vaccine for a number of years. Vaccine given 10/6-given AM-Tues. PM- reddened. Wed. AM 10/7-she could feel area when she moved her arm, 50 cent area. On 10/8 school nurse practioner reports 6-7 cm area. No other sxs, no PMD follow up. Today 10/9 area better.